Evidence mapPaperPMID 39757612Full record

ReviewInfectious disorders drug targets2025

Exploration of Phytochemicals as Anti-biofilm Agents against Pathogenic Bacteria: Their Potential and Challenges.

Debolina Banerjee, Poulomi Biswas, Kamalika Mazumder, Sangita Palai, Chowdhury Mobaswar Hossain, Sanmoy Karmakar, Kaushik Biswas

Abstract readReview
PubMed Publisher
In one paragraph

Review in Infectious disorders drug targets, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Debolina BanerjeeDepartment of Pharmacology and Biotechnology, Eminent College of Pharmaceutical Technology, Barbaria, Barasat, Kolkata, 700126, West Bengal, India.ORCID 0009-0006-6240-8089
Poulomi BiswasDepartment of Pharmacology and Biotechnology, Eminent College of Pharmaceutical Technology, Barbaria, Barasat, Kolkata, 700126, West Bengal, India.ORCID 0000-0001-9597-8746
Kamalika MazumderBCDA College of Pharmacy & Technology, Barasat, Kolkata, 700126, West Bengal, India.ORCID 0000-0002-3395-1334
Sangita PalaiDepartment of Pharmacology and Biotechnology, Eminent College of Pharmaceutical Technology, Barbaria, Barasat, Kolkata, 700126, West Bengal, India.ORCID 0000-0002-9785-2546
Chowdhury Mobaswar HossainDepartment of Pharmaceutical Science, Maulana Abul Kalam Azad University of Technology, Haringhata, Nadia-741249, West Bengal, India.ORCID 0000-0002-5283-7297
Sanmoy KarmakarDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata,700032, West Bengal, Kalkata, India.ORCID 0000-0003-2162-5061
Kaushik BiswasDepartment of Pharmacology and Biotechnology, Eminent College of Pharmaceutical Technology, Barbaria, Barasat, Kolkata, 700126, West Bengal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multicellular surface-attached populations of bacteria embedded in the extracellular matrix are known as biofilms. Bacteria generally preferred to grow as biofilms. Quorum sensing (QS), detection of density of cell population through gene regulation, has been found to play an important role in the production of biofilms. Biofilm formation can increase the severity of infections that can lead to morbidity or mortality. Bacteria living within biofilms have a higher pattern of adaptive resistance to antibiotics. Antibiotic resistance is a barrier in the treatment of biofilmsinduced acute to chronic infections such as post-surgery infections, surgery-associated wound infections, endocarditis, joint infections, burn-related wound infections occurred, ventilator-associated pneumonia, etc. So it is urgent to discover or find out potent new drugs in fight against infectious diseases such as biofilms-associated infections. Medicinal plants or herbs are a rich source for fighting with biofilms-mediated infections. Phytochemicals have exhibited significant effects in the prevention of biofilms formation against different bacteria that are causing infections. Purified compounds such as berberine, tetrandrine, embelin, xanthorrhizol, bakuchiol, etc., exhibited promising biofilm inhibition actions against different pathogenic bacteria. Plant extracts that contain several phytochemicals are evaluated for its biofilm's inhibition property, and have shown significant potential in biofilm formation. Antibiofilm agents act by distinct mechanisms such as inhibiting the adherence of biofilms in a surface, preventing the biofilm formations, disrupting the matured biofilms, etc. This study is intended to reiterate about possibilities of plant extracts and purified compounds in the treatment of the prevention of bacterial biofilms-related infections.

Indexed as

Anti-Bacterial AgentsBacteriaBiofilmsPhytochemicalsPlant ExtractsBacterial InfectionsHumansQuorum SensingAnti-Bacterial AgentsPhytochemicalsPlant Extractsantibiofilm agentsbacterial biofilmsbiofilm-associated infectionBiofilmsplant derived antimicrobial.quorum sensing

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.